About the LDN Fellowship

The Lysosomal Disease Network has now concluded accepting applications for the next LDN Fellowship. Utilizing NIH funding, this research grant provides $50,000 total costs (direct and indirect costs) for the period August 1, 2017 – July 31, 2018. The LDN Fellowship can support currently-ongoing research projects, as well as new research projects.

About the Research Grant Award:
A single award is typically announced near the end of July each year, and commences immediately with a grant period of August 1st of that year, to July 31st of the following year.

Applicant Criteria:

  1. Applicants should be a recent post-doctoral professional who will develop an interest in clinical research of lysosomal diseases. This could include physicians with training in relevant disciplines, as well as pharmacists, psychologists, or other suitably qualified professionals (i.e., MD, PhD, MD PhD, DO, PsyD, DDS, PharmD, DNP, etc.). Please note that this is a clinical research fellowship, not a bench research position, unless human specimens are a key aspect of the proposal.
  2. Applicants must identify a mentor with an appropriate track record in lysosomal disease research.
  3. Applicants need not be United States citizens, but must be allied with a United States-based institution qualified to receive funds from the National Institutes of Health.
  4. Applicants should use the NIH PHS 398 forms, but with these modifications:
    1. Research Plan, total of 2 page limit (plus literature cited on additional page(s))
    2. Training Plan written by applicant (goals, possible coursework/workshops, clinical activity, symposia)
    3. Role of Mentor in this research project
    4. Letter of Support from Mentor
    5. Description of research environment and resources relevant to this training program and research project (no more than one page)
  5. Biosketches are required – on NIH PHS 398 forms
    1. PI (the applicant)
    2. Mentor
  6. Cannot be based at the University of Minnesota, as one fellowship has already been awarded at this institution.

SUBMISSION DEADLINE: Application deadline was June 1, 2017. Incomplete or late applications were not accepted for review.

Completion of Forms:
Although the current NIH PHS 398 forms must be used (including Face Page, Budget and Budget Justification pages, etc.), the grant will be issued by the University of Minnesota to the applicant’s institution.

The fellowship application does not need to be vetted by the applicant’s institutional administration prior to submission.

The application should cite additional funds, if any, that will be used to support the applicant and the research project prior to, during, and after the Fellowship, in the “Other Support” section of the application (in the Biographical Sketch).

The current PHS 398 forms are available at this website: NIH PHS 398 forms

Application Review Criteria:
Applications will be reviewed for focus on “clinical research” (using human subjects and/or human tissues) of “lysosomal diseases” with priority given to those applicants who are likely to be mentored into a career with a focus on clinical research of lysosomal diseases.  The application will also be evaluated with respect to the applicant’s potential to submit a manuscript based on the research proposal to a peer-reviewed journal for publication.

Applications are required to be submitted by e-mail only (please do not send paper copies) by the specified deadline to this e-mail address: fellowship@nulllysosomaldiseasenetwork.org. Questions can also be sent to that e-mail address.

Thank you for your interest in this Fellowship.

Past and Present LDN Fellows

The following LDN Fellows received needed financial support from the LDN in order to provide experiences that developed their skills and expertise in clinical research benefitting the rare-disease patient community:

Comprehensive LDN Fellows List
To learn more about past LDN Fellows, read the LDN Fellowship articles in the March 2015 and October 2015 issues of Indications, the newsletter of the Lysosomal Disease Network.